Past, present and future of therapeutic strategies against amyloid-β peptides in Alzheimer’s disease: a systematic review

Alzheimer’s disease (AD) is the most prevalent neurodegenerative disease in ageing, affecting around 46 million people worldwide but few treatments are currently available. The etiology of AD is still puzzling, and new drugs development and clinical trials have high failure rates. Urgent outline of...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Ageing research reviews 2021-12, Vol.72, p.101496-101496, Article 101496
Hauptverfasser:	Jeremic, Danko, Jiménez-Díaz, Lydia, Navarro-López, Juan D.
Format:	Artikel
Sprache:	eng
Schlagworte:	Alzheimer Disease - drug therapy Alzheimer’s Amyloid Amyloid beta-Peptides Biomarkers Clinical trials Humans Hyperexcitability Immunotherapy MCI Neurodegenerative Diseases Therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!